China-Developed Artificial Skin Ready For Production
This article was originally published in PharmAsia News
Shaanxi Province has broken ground for its Research and Development Center for Tissue Engineering in Xi'an High-Tech Industrial Development Zone. With a total investment of RMB 120 million, the project is expected to realize a yearly revenue of RMB 1 billion when it goes into operation. The facility will have an annual output of 3 million cm2 of artificial skin, 30,000 corneas and 10 million cm2 of selective acellular double-layer dermal matrix produced by tissue engineering. Developed by Fourth Military Medical University, it is the nation's only such technology with independent intellectual property rights that can successfully produce engineered tissue products. The project makes China the second country to commercialize tissue engineering technology after the U.S. (Click here for more - Chinese Language)
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.